Sugi Predict

Sugi Predict / Compounds / SCHEMBL5454067

SCHEMBL5454067

SCHEMBL5454067

O=C(CBr)c1ccc2[nH]c(=O)oc2c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.73
▸ ALDH1A1 P00352 1/20 0.73
▸ CREBBP Q92793 1/20 0.60
▸ NOS1 P29475 1/20 0.50
▸ SMYD3 Q9H7B4 1/20 0.49
▸ GRIN2D O15399 1/20 0.47
▸ GRIN3B O60391 1/20 0.47
▸ GRIN1 Q05586 1/20 0.47
▸ GRIN2A Q12879 1/20 0.47
▸ GRIN2B Q13224 1/20 0.47
▸ GRIN2C Q14957 1/20 0.47
▸ GRIN3A Q8TCU5 1/20 0.47
▸ ENPP2 Q13822 6/20 0.46
▸ ESR1 P03372 1/20 0.45
▸ KCNH2 Q12809 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ PDE3B Q13370 1/20 0.44
▸ PDE3A Q14432 1/20 0.44
▸ OGT O15294 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31208294 1.00 KDM4E (0.73) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL10393915 0.88 KDM4E (0.69) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL19513027 0.88 KDM4E (0.56) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL4892442 0.85 KDM4E (0.66) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL9472025 0.84 KDM4E (0.73) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL172191 0.84 ALDH1A1 (1.00) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL2583451 0.84 KDM4E (0.73) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL118687 0.82 KDM4E (0.78) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL12266541 0.82 ALDH1A1 (0.69) KDM4EALDH1A1CREBBPNOS1SMYD3
SCHEMBL9683724 0.82 ALDH1A1 (0.69) KDM4EALDH1A1CREBBPNOS1SMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0049203-A1 Benzoxazolinones substituted in the 6-position by an amino-alcohol or amino-ketone chain, their preparation and their therapeutic use RIOM LABORATOIRES- C.E.R.M. (Société Anonyme) (FR) 1982-04-07 — — EP claimed
US-20240409533-A1 HMOX1 INDUCERS Astellas Engineered Small Molecules US, Incorporated 2024-12-12 — — US disclosed
US-12071433-B2 HMOX1 inducers Astellas Engineered Small Molecules US, Incorporated (US) 2024-08-27 — — US disclosed
US-20240051952-A1 HMOX1 INDUCERS Astellas Engineered Small Molecules US, Incorporated 2024-02-15 — — US disclosed
US-20220177460-A1 HMOX1 INDUCERS Astellas Engineered Small Molecules US, Incorporated 2022-06-09 — — US disclosed
EP-3952990-A1 HMOX1 INDUCERS Mitobridge, Inc. (US) 2022-02-16 — — EP disclosed
CN-113874074-A HMOX1 inducers 米托布里奇公司 2021-12-31 — — CN disclosed
WO-2020210339-A1 HMOX1 INDUCERS MITOBRIDGE, INC. (US) 2020-10-15 — — WO disclosed
WO-2020210339-A1 HMOX1 INDUCERS MITOBRIDGE, INC. (US) 2020-10-15 — — WO disclosed
US-10766888-B1 HMOX1 inducers MITOBRIDGE INC. (US) 2020-09-08 — — US disclosed
WO-2013093484-A1 PYRIDINONE AND PYRIMIDINONE DERIVATIVES AS FACTOR XIA INHIBITORS ONO PHARMACEUTICAL CO., LTD. (JP) 2013-06-27 — — WO disclosed
US-20070232673-A1 2-Imino-benzimidazoles ABBOTT LABORATORIES 2007-10-04 — — US disclosed
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 — — US disclosed
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 — — US disclosed
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 — — US disclosed
EP-1748993-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-02-07 — — EP disclosed
WO-2005116000-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2005-12-08 — — WO disclosed
US-RE34201-E Analgesics ANAQUEST, INC. (US) 1993-03-23 — — US disclosed
US-5053411-A Analgesics ANAQUEST, INC. (US) 1991-10-01 — — US disclosed
EP-0049203-A1 Benzoxazolinones substituted in the 6-position by an amino-alcohol or amino-ketone chain, their preparation and their therapeutic use RIOM LABORATOIRES- C.E.R.M. (Société Anonyme) (FR) 1982-04-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10766888-B1 HMOX1 inducers HMOX1, HMOX2, HMBS KDM4E 2510/4885ALDH1A1 332/4885CREBBP 1125/4885
US-20070203155-A1 Compounds And Compositions As Ppar Modulators PPARG, PPARA, PPARD KDM4E 3328/4885ALDH1A1 1651/4885CREBBP 48/4885
US-20240409533-A1 HMOX1 INDUCERS HMOX1, HMOX2, HMBS KDM4E 2510/4885ALDH1A1 332/4885CREBBP 1125/4885
US-12071433-B2 HMOX1 inducers HMOX1, HMOX2, HMBS KDM4E 2606/4885ALDH1A1 223/4885CREBBP 1050/4885
US-20240051952-A1 HMOX1 INDUCERS HMOX1, HMOX2, QSOX1 KDM4E 4001/4885ALDH1A1 266/4885CREBBP 1787/4885
US-20220177460-A1 HMOX1 INDUCERS HMOX1, HMOX2, HMBS KDM4E 2606/4885ALDH1A1 223/4885CREBBP 1050/4885
US-20070232673-A1 2-Imino-benzimidazoles CYP2C19, UGT2B7, UGT2B17 KDM4E 2704/4885ALDH1A1 39/4885CREBBP 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.